Pacira absorbs GQ Bio for $32M; Layoffs at Eisai and CRISPR Therapeutics

Plus, news about Recursion, Nxera, Viatris and DualityBio: Pacira BioSciences takes on GQ Bio: The non-opioid pain biotech is spending $32 million to buy the remaining ...

Feb 28, 2025 - 16:15

Pacira absorbs GQ Bio for $32M; Layoffs at Eisai and CRISPR Therapeutics

Plus, news about Recursion, Nxera, Viatris and DualityBio: Pacira BioSciences takes on GQ Bio: The non-opioid pain biotech is spending $32 million to buy the remaining ...